TELA Bio, Inc.

TELA Net buying

CIK 0001561921 #4919 in the set updated 17 Sep 2026

Bought (120 mo)

$51.77M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$4.22M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$4.22M

7 of 7 sales

Net

+$47.55M

+$47.55M against sales at will

By person

32 insiders · 254 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

EW HEALTHCARE PARTNERS FUND 2, L.P. entity

10% owner

$35.56M (186)

—

+$35.56M

14,340,779

31.94%

$15.18M

+84.3%

Opaleye Management Inc. entity

Former 10% Owner.

$3.95M (36)

—

+$3.95M

124,813

0.2780%

$132.15K

—

Oliva Adele C

Director

$2.00M (1)

—

+$2.00M

1,751,100

3.90%

$1.85M

+138.3%

Quaker BioVentures II LP entity

10% owner

$2.00M (1)

—

+$2.00M

0

0.0000%

$0.00

−100.0%

ORBIMED ADVISORS LLC entity

10% owner

$5.00M (1)

$3.81M (6)

+$1.19M

5,434,784

12.11%

$5.75M

+29.0%

Azarbarzin Kurt

Director

$1.12M (2)

—

+$1.12M

532,951

1.19%

$564.29K

+184.4%

Zuga Matt

Director

$1.12M (2)

—

+$1.12M

514,481

1.15%

$544.73K

+174.6%

Cuca Roberto

COO and CFO

$327.80K (7)

—

+$327.80K

257,377

0.5733%

$272.51K

+3,876%

KOBLISH ANTONY

Chief Executive Officer

$249.97K (2)

—

+$249.97K

586,210

1.31%

$620.68K

—

RTW INVESTMENTS, LP entity

10% owner

$277.12K (1)

$407.62K (1)

−$130.50K

1,139,358

2.54%

$1.21M

−1.1%

Capper Joseph H

Director

$78.44K (2)

—

+$78.44K

104,827

0.2335%

$110.99K

—

Talmo Paul

Chief Technology Officer

$50.00K (1)

—

+$50.00K

173,436

0.3863%

$183.63K

+469.2%

Firestone Gregory A.

Chief Business Officer

$29.69K (2)

—

+$29.69K

139,307

0.3103%

$147.50K

+623.4%

Getz Heather C

Chief Executive Officer

$18.78K (2)

—

+$18.78K

532,500

1.19%

$563.81K

+10,550%

Ellis Ronald J. Jr.

Director

—

—

—

774,056

1.72%

$819.57K

+299.6%

Friedman Ashley

Director

—

—

—

611,333

1.36%

$647.28K

+130.0%

Blizard Jeffrey

President

—

—

—

205,125

0.4569%

$217.19K

—

PERSENAIRE MAARTEN

Chief Medical Officer

—

—

—

90,887

0.2024%

$96.23K

+56.4%

Smeykal Megan

Chief Accounting Officer

—

—

—

66,873

0.1490%

$70.81K

+581.1%

Murphy Peter C.

Chief Commercial Officer

—

—

—

48,129

0.1072%

$50.96K

+13,269%

Plovanic William J.

Director

—

—

—

44,530

0.0992%

$47.15K

—

Greenhalgh Ellis Skott

Chief Technology Officer

—

—

—

27,826

0.0620%

$29.46K

+673.4%

THOMAS PAUL

Director

—

—

—

23,600

0.0526%

$24.99K

—

NEELS GUIDO J

Director

—

—

—

23,600

0.0526%

$24.99K

—

NOHRA GUY P

Director

—

—

—

23,600

0.0526%

$24.99K

—

Rocchio Betty Jo

Director

—

—

—

23,600

0.0526%

$24.99K

—

Burgess Vincent J

Director

—

—

—

23,330

0.0520%

$24.70K

—

O'Brien Federica F.

Director

—

—

—

18,470

0.0411%

$19.56K

—

EVANS DOUGLAS G

Director

—

—

—

18,470

0.0411%

$19.56K

—

COLLERAN LISA N

Director

—

—

—

18,470

0.0411%

$19.56K

—

Brennan Nora

Chief Financial Officer

—

—

—

17,696

0.0394%

$18.74K

+9,898%

Nosenzo John

Director

—

—

—

6,270

0.0140%

$6.64K

—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 232

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 74

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 7

Transactions with no price 0

Shares from compensation/vesting 8,659,818

Sales filed before the plan box existed 1

History held since 13 Nov 2019